"This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public."
This is HCP only content
The unique asymmetric bevel of NANOPASS cuts the skin instead of puncturing it. This decreases the resistance while penetrating the skin* – designed to reduce pain.
* Intra company data
The special thin pen needle size of only 32.5G (0.22 mm) causes less skin trauma than larger needle sizes.
The large inner diameter of NANOPASS 32.5 optimizes the insulin flow for an easy insulin injection.
Nanopass®32.5G is not sold in North America.
Please note that some products may not be available in all regions, check with your local TERUMO Pharmaceuticals Solutions contact for details.
Does not contain components made of natural rubber latex.
1 Patented technology2 Intra company data show less puncture resistance for the asymmetric edge compared to a standard 3-bevel. Lower puncture resistance is related to lower pain. (T. Asakura, 2013, Jpn J Med Pharm Sci 69(1):147-155)3 The size of the perforation scar correlates with the outer diameter of the needle (T. Asakura, H. Seino, 2004, Jpn J Pharm. Health Care Sci., 30(06):368-376)4 For detailed list of compatible devices see NANOPASS pen needle boxes
Our sales representatives are here for you
Didn't find your product?